Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in LPCN — Lipocine Inc.

CIK 1179392 NEW YORK, NY
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$217,310
-$52,352 QoQ
Shares Held
84,887
+151.5% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 36 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. LPCN ranks #294 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in LPCN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $217,310 84,887
2026-03-31 $269,662 33,750
2023-06-30 $55,606 11,033
2023-03-31 $80,764 253,977
2022-12-31 $115,133 289,281
2022-09-30 $146,321 325,159
2022-06-30 $367,401 458,678
2022-03-31 $493,295 360,070
2021-12-31 $101,676 102,600
2020-06-30 $122,094 96,900